4-Butyl-1,2,2,6,6-pentamethylpiperidine | 112500-84-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-Butyl-1,2,2,6,6-pentamethylpiperidine
• CAS: 112500-84-2
• 化学式: C₁₄H₂₉N
• 分子量: 211.39
• InChiKey: KLFAIGMXZNYSJP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM
  申请人：MERCK PATENT GMBH

  公开号：US20180216005A1

  公开（公告）日：2018-08-02

  Compounds of the formula I, and liquid-crystalline media, preferably having a nematic phase and negative dielectric anisotropy, comprising a) one or more compounds of the formula I and one or more compounds selected from b) one or more compounds of formula II and/or c) one or more compounds selected from compounds of formulae III-1 to III-4 and formula B Methods for making and using these liquid-crystalline media in electro-optical displays, particularly in active-matrix displays based on the VA, ECB, PALC, FFS or IPS effect and the displays which contain these media. Methods for stabilizing liquid-crystalline media with compounds of formula I, where the liquid-crystalline media comprise one or more compounds of the formula II and one or more compounds selected from compounds of the formulae III-1 to III-4 and formula B.

  公式I的化合物和液晶介质，最好具有向列相和负介电各向异性，包括a) 一个或多个公式I的化合物和一个或多个选自b) 一个或多个公式II的化合物和/或c) 一个或多个选自公式III-1至III-4和公式B的化合物的液晶介质的方法。制备和使用这些液晶介质的方法在电光显示中，特别是基于VA、ECB、PALC、FFS或IPS效应的主动矩阵显示和包含这些介质的显示器。一种使用公式I的化合物稳定液晶介质的方法，其中液晶介质包括一个或多个公式II的化合物和一个或多个选自公式III-1至III-4和公式B的化合物。
• Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US11180474B2

  公开（公告）日：2021-11-23

  Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R3, R4, R5, m, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

  公开了式 (I) 的化合物或其盐，其中 R1、R3、R4、R5、m 和 n 在本文中定义。还公开了使用此类化合物作为通过 Toll 样受体 7 或 8 或 9 信号转导的抑制剂的方法，以及包含此类化合物的药物组合物。这些化合物可用于治疗炎症和自身免疫性疾病。
• DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20210292300A1

  公开（公告）日：2021-09-23

  Disclosed are compounds of Formula (I) or a salt thereof, wherein R 1 ; R 3 , R 4 , R 5 , m, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.